Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)

v3.22.1
Financial Instruments - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets    
Marketable equity securities $ 19,051  
Liabilities    
Contingent consideration (Note 3) 2,768  
Fair Value, Recurring    
Assets    
Marketable equity securities 19,051  
Liabilities    
Contingent consideration (Note 3) 2,768 $ 2,700
Total liabilities, fair value disclosure   2,700
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Assets    
Marketable equity securities 19,051  
Liabilities    
Contingent consideration (Note 3) 0 0
Total liabilities, fair value disclosure   0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)    
Assets    
Marketable equity securities 0  
Liabilities    
Contingent consideration (Note 3) 0 0
Total liabilities, fair value disclosure   0
Fair Value, Recurring | Significant Unobservable Inputs (Level 3)    
Assets    
Marketable equity securities 0  
Liabilities    
Contingent consideration (Note 3) $ 2,768 2,700
Total liabilities, fair value disclosure   $ 2,700